Biomerica Gains Regulatory Approval for At-Home Cancer Test in Vietnam

Biomerica enters Vietnam with its EZ Detect™ colorectal cancer screening test, addressing a critical healthcare gap with a 45% survival rate and aiming to use this as a blueprint for global expansion.

A significant regulatory clearance in Vietnam has opened a major new Southeast Asian market for medical diagnostics firm Biomerica. The company announced it has received authorization from health authorities in Hanoi to distribute its EZ Detect™ colorectal cancer screening test nationwide.

This move provides Biomerica with access to a population exceeding 100 million people. The test, designed for at-home use, delivers preliminary results indicating potential signs of colorectal cancer or other bowel diseases in approximately two minutes.

Addressing a Critical Healthcare Gap

The strategic importance of this market entry is underscored by a pressing medical need. Current five-year survival rates for colorectal cancer in Vietnam stand at just 45%. This contrasts sharply with the 91% survival rate observed in the United States, where early screening programs are well-established. With colorectal cancer accounting for nearly 10% of all cancer cases in Vietnam, demand for accessible screening solutions is substantial.

To facilitate its market penetration, Biomerica is leveraging a partnership with a major local distributor. The product will be made available through an extensive network that includes pharmacies, hospitals, clinics, and digital channels. Consumer acceptance for this type of testing appears strong, supported by research from Johns Hopkins University indicating 92% of respondents preferred Biomerica's solution over conventional screening methods.

A Template for Global Expansion

Company strategists view the Vietnamese launch as a potential blueprint for broader international growth. Medical experts project a sharp rise in colorectal cancer cases across emerging economies by 2050. In anticipation, Biomerica is already focusing on similar expansion initiatives in regions such as Africa and Latin America. Establishing robust distribution infrastructure in Vietnam is considered a foundational step for these future endeavors.

The approval represents a notable milestone for Biomerica's global commercial strategy, potentially accelerating its presence in one of Asia's fastest-growing healthcare sectors.